Teva expects decline in profit and revenue ahead of Q3 earnings release
TEVA Teva- Pharmaceutical Industries Ltd
$43.24 +1.98%
View chart & analysis → 
- 1Revenue is expected to reach the Wall Street estimate of $4.28 billion with earnings per share expected at $0.70.
- 2Teva's profit is expected to decrease by 6.7% and revenue is expected to decrease by 4.5% this quarter.
- 3Management warned of the possibility that fourth-quarter revenue may decline compared to last year.
So what's the key point?
Teva's revenue and profit for this quarter are expected to decrease. Investors should be cautious as performance may fall below expert expectations.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.